trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Visceral Pain D059265 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Ganglioneuroma D005729 2 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Rahman R et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. 2010 Mol. Cancer Ther. pmid:20643785
Tong JH et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. 2010 BMC Cancer pmid:20525238
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Trtkova K et al. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB. 2010 Neoplasma pmid:20568894
Desai D et al. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. 2010 Bioorg. Med. Chem. Lett. pmid:20167479
Ishimaru N et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. 2010 Biochem. Biophys. Res. Commun. pmid:20188708
Popova AP et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20190033
Chatterjee A et al. An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. 2010 Org. Lett. pmid:20104892
Kicic A et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. 2010 Am. J. Respir. Crit. Care Med. pmid:20110557
Su Y et al. Human RecQL4 helicase plays critical roles in prostate carcinogenesis. 2010 Cancer Res. pmid:21045146
Taura A et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. 2010 Neuroscience pmid:20060033
Shiau RJ et al. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. 2010 Eur J Nutr pmid:19639378
Gao A et al. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. 2010 Toxicol. Lett. pmid:20230882
Majid S et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. 2010 Cancer Res. pmid:20332239
Khobta A et al. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. 2010 Nucleic Acids Res. pmid:20338881
Kim SH et al. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. 2010 Breast Cancer Res. pmid:20388208
Himaki T et al. Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. 2010 Anim. Sci. J. pmid:20887307
Peidis P et al. HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. 2010 Aging (Albany NY) pmid:21076179
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Choi JH et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. 2010 Biochem. Biophys. Res. Commun. pmid:19914212
Kobori A et al. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. 2010 World J. Gastroenterol. pmid:20480520
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226
Barua S and Rege K The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. 2010 Biomaterials pmid:20452664
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Wallace DM and Cotter TG Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina. 2009 J. Neurosci. Res. pmid:18951482
Li M et al. Upregulation of human with-no-lysine kinase-4 gene expression by GATA-1 acetylation. 2009 Int. J. Biochem. Cell Biol. pmid:18793746
Patel V et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. 2009 J. Med. Chem. pmid:19317450
García-Villegas R et al. Identification and functional characterization of the promoter of the mouse sodium-activated sodium channel Na(x) gene (Scn7a). 2009 J. Neurosci. Res. pmid:19326446
Seo J et al. Differential expression of stromal cell-derived factor 1 in human brain microvascular endothelial cells and pericytes involves histone modifications. 2009 Biochem. Biophys. Res. Commun. pmid:19289100
Chiou SK and Hoa N Up-regulation of GADD45alpha expression by NSAIDs leads to apoptotic and necrotic colon cancer cell deaths. 2009 Apoptosis pmid:19757064
Vire B et al. Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions. 2009 PLoS ONE pmid:19759901
Beebe LF et al. Cytochalasin B and trichostatin a treatment postactivation improves in vitro development of porcine somatic cell nuclear transfer embryos. 2009 Cloning Stem Cells pmid:19780698
Olsen CA and Ghadiri MR Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. 2009 J. Med. Chem. pmid:19705846
Kee HJ and Kook H Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. 2009 J. Mol. Cell. Cardiol. pmid:19729022
Ong DC et al. LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. 2009 Oncogene pmid:19734946
Alao JP et al. Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay. 2009 Mol. Cancer Ther. pmid:19723888
Bennett KL et al. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma. 2009 PLoS ONE pmid:19742317
Meng CF et al. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. 2009 Zhonghua Wei Chang Wai Ke Za Zhi pmid:19742343
Hostetter CL et al. Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. 2009 Cancer Lett. pmid:19013015
Heo H et al. Suppression of caspase-11 expression by histone deacetylase inhibitors. 2009 Biochem. Biophys. Res. Commun. pmid:19013432
Kekatpure VD et al. HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. 2009 J. Biol. Chem. pmid:19158084
Sutcliffe EL et al. Dynamic histone variant exchange accompanies gene induction in T cells. 2009 Mol. Cell. Biol. pmid:19158270
Bagui TK et al. Inhibition of p27Kip1 gene transcription by mitogens. 2009 Cell Cycle pmid:19158484
Wang X et al. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. 2009 Growth Factors pmid:19107653
Cao Y et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19966229
Trunzer M et al. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. 2009 J. Med. Chem. pmid:19108654
Smil DV et al. Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19111466
Azzi A et al. Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors. 2009 Exp. Parasitol. pmid:19094990
Hambach L et al. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. 2009 Blood pmid:19096014
Araki H et al. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues. 2009 Exp. Hematol. pmid:19501128
Pulukuri SM et al. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer. 2009 Oncogene pmid:19503093
Tian F et al. Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. 2009 J. Neurochem. pmid:19476549
Han SB and Lee JK Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. 2009 Arch. Pharm. Res. pmid:19407980
Lee JH et al. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex. 2009 J. Mol. Biol. pmid:19573535
Gan YH and Zhang S PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. 2009 Oral Oncol. pmid:19574087
Wang XX and Fu L [Recent advances in DNA demethylation in tumor therapy]. 2009 Zhonghua Bing Li Xue Za Zhi pmid:19575888
Sawarkar R et al. Histone deacetylases regulate multicellular development in the social amoeba Dictyostelium discoideum. 2009 J. Mol. Biol. pmid:19576222
Hsu PY et al. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. 2009 Cancer Res. pmid:19549897
Noh H et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. 2009 Am. J. Physiol. Renal Physiol. pmid:19553350
Jonsen MD et al. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain. 2009 Mol. Endocrinol. pmid:19556346
Link PA et al. Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells. 2009 Mol. Cancer Res. pmid:19531572
Chen IH et al. Cytotoxic triterpenoids from the stems of Microtropis japonica. 2009 J. Nat. Prod. pmid:19534471
Casero RA and Woster PM Recent advances in the development of polyamine analogues as antitumor agents. 2009 J. Med. Chem. pmid:19534534
Dubois F et al. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. 2009 Mol. Biochem. Parasitol. pmid:19538992
Pang M et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. 2009 Am. J. Physiol. Renal Physiol. pmid:19640900
Monks A et al. Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts. 2009 Anticancer Drugs pmid:19606018
Hemmatazad H et al. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. 2009 Arthritis Rheum. pmid:19404935
Gaymes TJ et al. Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes. 2009 Haematologica pmid:19407318
Kim SN et al. Regulation of adipocyte differentiation by histone deacetylase inhibitors. 2009 Arch. Pharm. Res. pmid:19407971
Hirose N et al. ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. 2009 Biochem. Biophys. Res. Commun. pmid:19422799
Park SJ et al. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway. 2009 Biochem. Pharmacol. pmid:19426671
Piotrowska H and Jagodzinski PP Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells. 2009 Arch. Med. Res. pmid:19427965
López-Soto A et al. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. 2009 Oncogene pmid:19430493
Kim W et al. Histone acetyltransferase GCN5 interferes with the miRNA pathway in Arabidopsis. 2009 Cell Res. pmid:19436261
Yoshida M Chemical genomics: a key to the epigenome - an interview with Minoru Yoshida. Interview by Saadi Khochbin. 2009 Int. J. Dev. Biol. pmid:19412886
Han DW et al. Epigenetic hierarchy governing Nestin expression. 2009 Stem Cells pmid:19415779
Derks S et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. 2009 Carcinogenesis pmid:19329758
Liu X et al. The improvement of adenovirus vector production by increased expression of coxsackie adenovirus receptor. 2009 Biotechnol. Lett. pmid:19330491
Yeh JR et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. 2009 Nat. Chem. Biol. pmid:19172146
Kusakabe M et al. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. 2009 Biochem. Biophys. Res. Commun. pmid:19878646
Ma X et al. Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach. 2009 Mol. Cancer Ther. pmid:19887557
Kawamura T et al. Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts. 2009 Dig. Dis. Sci. pmid:18629644
von Dassow G et al. Action at a distance during cytokinesis. 2009 J. Cell Biol. pmid:20008563
Kakihana M et al. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. 2009 J Thorac Oncol pmid:20009910
Peng DF et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. 2009 Gut pmid:18664505
O'Leary DA et al. Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening. 2009 PLoS ONE pmid:20020055
Halaban R et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. 2009 PLoS ONE pmid:19234609
Maalouf WE et al. Trichostatin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term. 2009 BMC Dev. Biol. pmid:19210795
Sakurai T et al. Induction of endogenous interferon tau gene transcription by CDX2 and high acetylation in bovine nontrophoblast cells. 2009 Biol. Reprod. pmid:19211809
Chakravorty M et al. IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin. 2009 Int. J. Biochem. Cell Biol. pmid:19166966
Zhang D et al. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. 2009 Ai Zheng pmid:19958621
Lu MC et al. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. 2009 Arch. Toxicol. pmid:18709356
Sharma A et al. Trichostatin a inhibits corneal haze in vitro and in vivo. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19168895
Li X et al. Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. 2009 Blood pmid:19864643
Gray SG et al. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. 2009 Eur. J. Cancer pmid:19818596
Lee SH et al. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. 2009 Oncogene pmid:18850007
Katsura T et al. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. 2009 Cancer Gene Ther. pmid:18949013